Stem Cells, Vol 13, 186-197, Copyright © 1995 by AlphaMed Press

ORIGINAL ARTICLES

Stem cell factor augments tumor necrosis factor-granulocyte-macrophage colony-stimulating factor-mediated dendritic cell hematopoiesis

F Santiago-Schwarz, DA Rappa, K Laky and SE Carsons
Division of Rheumatology, Allergy & Immunology, Winthrop University Hospital, Mineola, New York, USA.

We describe the effects of stem cell factor (SCF) on the dendritic cell (DC) pathway and provide evidence for the existence of a post granulocyte-macrophage colony-forming unit (GM-CFU) DC progenitor. When employed with cytokines regulating DC development (tumor necrosis factor [TNF] + GM colony-stimulating factor [GM-CSF]), SCF increased the size of monocyte (mono) and mono-DC colonies arising from cord blood CD34+ progenitor cells. The overall plating efficiency of these colonies increased approximately threefold, as compared with growth in TNF + GM-CSF. Most (approximately 70%) of the CFUs were mono-DC CFU, and SCF did not alter the proportion of mono-DC CFU to mono-CFU obtained with TNF + GM-CSF alone. Proliferation, as measured by thymidine uptake and manual cell counts, at least doubled and occurred earlier (by day 4). In long-term cultures established with TNF + GM-CSF + SCF, high levels of proliferation were prolonged for up to three weeks. These were associated with extended DC development and the capacity to form 2 degree mono-DC colonies. There was no induction of polymorphonuclear (PMN) cells in 2 degree cultures treated with either GM-CSF, GM-CSF + SCF or GM-CSF + granulocyte CSF (G-CSF), implying that the DC progenitor being replated was post GM-CFU. DC progeny arising in the presence of SCF exhibited typical DC features including: the lack of nonspecific esterase and phagocytic activity, the presence of class II major histocompatibility complex (MHC) antigens, the absence of CD14 antigens, and the ability to induce a potent mixed leukocyte reaction. Thus, SCF augments DC growth from progenitor cells without altering the developmental commitment instituted by TNF + GM-CSF. This enhancement follows the same general mechanisms previously reported for SCF- mediated lineage enhancement, i.e., increased colony size, number and plating capacity.

This article has been cited by other articles:

				F. Santiago-Schwarz, P. Anand, S. Liu, and S. E. Carsons Dendritic Cells (DCs) in Rheumatoid Arthritis (RA): Progenitor Cells and Soluble Factors Contained in RA Synovial Fluid Yield a Subset of Myeloid DCs That Preferentially Activate Th1 Inflammatory-Type Responses J. Immunol., August 1, 2001; 167(3): 1758 - 1768. [Abstract] [Full Text] [PDF]

				Y. Gazitt Immunologic Profiles of Effector Cells and Peripheral Blood Stem Cells Mobilized with Different Hematopoietic Growth Factors Stem Cells, November 1, 2000; 18(6): 390 - 398. [Abstract] [Full Text]

				F. Santiago-Schwarz, M. McCarthy, J. Tucci, and S. E. Carsons Neutralization of Tumor Necrosis Factor Activity Shortly After the Onset of Dendritic Cell Hematopoiesis Reveals a Novel Mechanism for the Selective Expansion of the CD14-Dependent Dendritic Cell Pathway Blood, August 1, 1998; 92(3): 745 - 755. [Abstract] [Full Text] [PDF]

				S. D. Lyman and S. E. W. Jacobsen c-kit Ligand and Flt3 Ligand: Stem/Progenitor Cell Factors With Overlapping Yet Distinct Activities Blood, February 15, 1998; 91(4): 1101 - 1134. [Full Text] [PDF]

				J. I. Mayordomo, T. Zorina, W. J. Storkus, L. Zitvogel, M. D. Garcia-Prats, A. B. DeLeo, and M. T. Lotze Bone Marrow-Derived Dendritic Cells Serve as Potent Adjuvants for Peptide-Based Antitumor Vaccines Stem Cells, March 1, 1997; 15(2): 94 - 103. [Abstract] [Full Text]

				R Thomas and P. Lipsky Dendritic cells: origin and differentiation Stem Cells, March 1, 1996; 14(2): 196 - 206. [Abstract]

				F Santiago-Schwarz, J Tucci, and S. Carsons Endogenously produced interleukin 6 is an accessory cytokine for dendritic cell hematopoiesis Stem Cells, March 1, 1996; 14(2): 225 - 231. [Abstract]